Shanghai HeartCare Medical Technology Corporation Limited
HKEX:6609.HK
20 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 232.344 | 183.032 | 90.089 | 14.562 | 0 |
| Cost of Revenue
| 68.585 | 58.699 | 35.139 | 7.475 | 0 |
| Gross Profit
| 163.759 | 124.333 | 54.95 | 7.087 | 0 |
| Gross Profit Ratio
| 0.705 | 0.679 | 0.61 | 0.487 | 0 |
| Reseach & Development Expenses
| 123.831 | 153.693 | 76.306 | 51.134 | 51.11 |
| General & Administrative Expenses
| 74.636 | 71.466 | 115.888 | 27.356 | 7.38 |
| Selling & Marketing Expenses
| 79.246 | 96.527 | 51.129 | 14.278 | 1.039 |
| SG&A
| 153.882 | 167.993 | 167.017 | 41.634 | 8.419 |
| Other Expenses
| 0 | -11.876 | -8.987 | 120.66 | 16.247 |
| Operating Expenses
| 266.502 | 309.81 | 234.336 | 213.428 | 75.776 |
| Operating Income
| -126.87 | -198.566 | -196.312 | -213.767 | -75.708 |
| Operating Income Ratio
| -0.546 | -1.085 | -2.179 | -14.68 | 0 |
| Total Other Income Expenses Net
| 23.95 | -2.683 | -1.594 | -2.416 | 3.046 |
| Income Before Tax
| -102.92 | -201.249 | -197.906 | -216.183 | -75.498 |
| Income Before Tax Ratio
| -0.443 | -1.1 | -2.197 | -14.846 | 0 |
| Income Tax Expense
| -8.908 | -0.865 | -2.087 | -0.103 | -0.21 |
| Net Income
| -94.012 | -200.384 | -195.819 | -216.08 | -75.288 |
| Net Income Ratio
| -0.405 | -1.095 | -2.174 | -14.839 | 0 |
| EPS
| -2.47 | -5.24 | -5.86 | -5.56 | -1.94 |
| EPS Diluted
| -2.47 | -5.24 | -5.86 | -5.56 | -1.94 |
| EBITDA
| -68.503 | -167.313 | -183.339 | -206.194 | -73.366 |
| EBITDA Ratio
| -0.295 | -0.911 | -2.044 | -14.104 | 0 |